EverSource Wealth Advisors LLC Purchases 330 Shares of STERIS plc (NYSE:STE)

EverSource Wealth Advisors LLC increased its position in shares of STERIS plc (NYSE:STE) by 41.9% during the 4th quarter, Holdings Channel reports. The firm owned 1,117 shares of the medical equipment provider’s stock after acquiring an additional 330 shares during the period. EverSource Wealth Advisors LLC’s holdings in STERIS were worth $230,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Geode Capital Management LLC lifted its position in shares of STERIS by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock valued at $556,786,000 after acquiring an additional 17,007 shares in the last quarter. Principal Financial Group Inc. raised its stake in STERIS by 0.5% during the 4th quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider’s stock valued at $230,160,000 after purchasing an additional 5,419 shares during the period. Raymond James Financial Inc. purchased a new position in STERIS in the 4th quarter worth approximately $223,987,000. Franklin Resources Inc. lifted its holdings in STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in STERIS by 3.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider’s stock worth $117,136,000 after purchasing an additional 18,384 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on STE. JMP Securities reiterated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, Stephens reissued an “overweight” rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Price Performance

STERIS stock opened at $227.04 on Monday. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $219.17 and its 200 day moving average is $222.38. The company has a market cap of $22.31 billion, a price-to-earnings ratio of 48.20 and a beta of 0.92.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.